Condition
First Episode Psychosis
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
19 shownStratification and Treatment in Early Psychosis Study - ENHANCENCT06778564 · 2026-09-01
RECRUITINGDigital Strategies to Advance Help-Seeking - Aim 3NCT06774417 · 2026-02-02
RECRUITINGRecovery With Exogenous Ketones and AntipsychoticsNCT07122531 · 2025-08-26
RECRUITINGDigital Strategies to Advance Help-Seeking Aim 1 and 2NCT06774430 · 2025-04-07
RECRUITINGImplementation of Digital CBT for Insomnia in First Episode PsychosisNCT05050201 · 2021-04-20
UNKNOWNArtificial Intelligence to Measure Adherence to Oral MedicationNCT04046497 · 2020-11-20
UNKNOWNED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionNCT04298450 · 2020-09-21
COMPLETEDRepetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity BiotypesNCT04853485 · 2020-08-01
UNKNOWNUsing Digital Media Advertising to Reduce the Duration of Untreated PsychosisNCT03975400 · 2020-04-22
COMPLETEDEarly-Phase Schizophrenia: Practice-based Research to Improve OutcomesNCT04004364 · 2020-04-01
UNKNOWNEarly Psychosis Intervention - Spreading Evidence-based TreatmentNCT03919760 · 2020-01-03
COMPLETEDFeasibility of an Early Detection Program for Early Psychosis on a College CampusNCT03983421 · 2019-10-01
COMPLETEDOnTrackNY's Learning Healthcare SystemNCT04021719 · 2019-08-15
SUSPENDEDA Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticNCT03568500 · 2018-05-21
COMPLETEDOnTrackNY With the Option of Social Network MeetingsNCT03464162 · 2018-04-11
WITHDRAWNFeasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode PsychosisNCT03409393 · 2018-01-22
COMPLETEDThermoregulation Among Individuals With First-episode PsychosisNCT04369677 · 2017-01-17
WITHDRAWNRole of Minocycline in First Episode PsychosisNCT00916461 · 2006-05-01
COMPLETEDEfficacy and Safety With Ziprasidone in First-episode PsychosisNCT01157559
COMPLETEDCommon interventions
Active SMS InterventionBEHAVIORAL1AripiprazoleDRUG1CBD 100 mg/mL Oral SolutionDRUG1Coordinated Specialty Care (CSC)OTHER1Data infrastructureOTHER1Digital Medicine SystemDEVICE1Digital nudgeOTHER1Medium chain triglyceride oilOTHER1MinocyclineDRUG1NAVIGATEBEHAVIORAL1OlanzapineDRUG1PlaceboDRUG1PlaceboOTHER1QuetiapineDRUG1repetitive transcranial magnetic stimulation (rTMS)DEVICE1RisperidoneDRUG1search engine advertisement campaignBEHAVIORAL1Sham SMSBEHAVIORAL1SleepioDEVICE1Smartphone AppOTHER1Social Network MeetingsBEHAVIORAL1Stakeholder feedbackOTHER1The COPUS interventionOTHER1Treatment as UsualBEHAVIORAL1Usual CareOTHER1
Leading sponsors
Northwell Health
3
Centre for Addiction and Mental Health
2
Columbia University
2
Chonbuk National University Hospital
1
Copenhagen University Hospital, Rigshospitalet
1
Lisa Dixon
1
New York State Psychiatric Institute
1
NHS Greater Glasgow and Clyde
1
Nicholas Breitborde
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Shanghai Jiao Tong University School of Medicine
1
Stanley Medical Research Institute
1
Université de Sherbrooke
1
University of New Mexico
1
University of Oxford
1
Trial status mix
COMPLETED8
RECRUITING4
UNKNOWN4
WITHDRAWN2
SUSPENDED1
Phase mix
NA9
PHASE43
PHASE11
PHASE21
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.